Zyprexa

Lilly shares rose 5 cents to $57.22 on the New York Stock Exchange.

In the medical-devices sector, shares of syringe maker Becton Dickinson & Co.

surged to a new 52-week high after the company reported a 12 percent rise in first-quarter profit to $217.9 million, or 85 cents per share, from $195.4 million, or 75 cents per share, last year.

Revenue grew by 10 percent to $1.41 billion from $1.29 billion a year ago.

Analysts estimated first-quarter earnings of 76 cents on revenue of $1.38 billion.

Shares of Franklin Lakes, N.J.-based Becton rose $4, or 6.8 percent, to $63.11 on the NYSE at above average volume.

Shares earlier hit a new 52-week high of $63.36, surpassing a previous one of $62.38, and have risen from a 52-week low of $49.71 in October.

Baxter International Inc.

reported more than double its profit from the fourth quarter last year but missed Wall Street expectations for sales, and offered a weak outlook for the year, sending shares down.

The Deerfield, Ill.-based company reported net profit of $292 million, or 46 cents per share, from $106 million, or 17 cents per share, a year ago.

Excluding charges, the company reported earnings from continuing operations of $379 million, or 60 cents per share.

Revenue fell 4 percent to $2.49 billion from $2.6 billion a year ago, owing to a recall and seizure of so...

Read more...